Related Experiment Videos

Ethyl octylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase

S Y Wu1, J E Casida

  • 1Department of Environmental Science, Policy and Management, University of California, Berkeley 94720-3112, USA.

Insights

This study identifies potent organophosphorus compounds that inhibit neuropathy target esterase (NTE). While some compounds strongly inhibit NTE, only ethyl octylphosphonofluoridate unexpectedly induced organophosphorus-induced delayed neuropathy (OPIDN) in hens.

Area of Science:

  • Biochemistry
  • Toxicology
  • Neuroscience

Background:

  • Organophosphorus compounds are known to cause delayed neurotoxicity.
  • Neuropathy target esterase (NTE) inhibition is a key factor in organophosphorus-induced delayed neuropathy (OPIDN).
  • Structure-activity relationships of NTE inhibitors are crucial for understanding OPIDN pathogenesis.

Purpose of the Study:

  • To investigate the relationship between NTE inhibition and OPIDN.
  • To identify potent in vitro NTE inhibitors and assess their neuropathic effects in vivo.
  • To explore structure-activity relationships for novel organophosphorus compounds.

Main Methods:

  • Structure-activity studies of alkyl alkylphosphonofluoridates and dialkyl phosphorofluoridates.
  • In vitro enzyme inhibition assays to determine NTE inhibition potency (I50).
  • In vivo studies in hens to evaluate neuropathic effects and NTE inhibition levels.

Main Results:

  • Several alkyl octylphosphonofluoridates and dialkyl phosphorofluoridates demonstrated exceptional in vitro NTE inhibition (0.04-0.14 nM I50).
  • Optimal potency was linked to specific alkyl and alkoxy group lengths on phosphorus (12-16 atoms).
  • Ethyl octylphosphonofluoridate induced OPIDN, while the structurally similar 2-iodoethyl analog did not, despite potent NTE inhibition.

Conclusions:

  • Highly potent NTE inhibitors were synthesized and characterized.
  • The induction of OPIDN is not solely dependent on the degree of NTE inhibition.
  • Differences in the 'aging' of inhibited NTE may explain the differential neuropathic effects observed.

Related Concept Videos